- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07789236
Mandala Coloring and Music for Cancer Fear and Screening Anxiety
The Effect of Mandala Coloring and Music Interventions on Cancer Fear and Screening Anxiety Among Individuals Applying to Cancer Early Diagnosis, Screening and Training Centers (KETEM): A Randomized Controlled Trial
Cancer screening is important for detecting cancer at an early stage. However, women attending cancer screening may experience fear of cancer and anxiety related to the screening process. Simple, non-drug approaches that promote relaxation may help reduce these feelings and make the screening experience more comfortable.
The purpose of this randomized controlled study is to determine whether a combined mandala coloring and music intervention can reduce cancer fear and anxiety among women attending a Cancer Early Diagnosis, Screening and Training Center (KETEM) for cancer screening.
Women aged 30 to 65 years who attend the KETEM unit for their first or routine cancer screening, meet the study eligibility criteria, and agree to participate will be included in the study. Participants will be randomly assigned to one of two groups: an intervention group or a control group.
Participants in the intervention group will color a mandala for 20 minutes while listening to slow-tempo instrumental music. The intervention will take place in the KETEM waiting area. Participants in the control group will receive the standard information and routine services provided at KETEM without the mandala coloring and music intervention.
Cancer fear and anxiety will be assessed using questionnaires before and after the intervention. The researchers will compare the results between the intervention and control groups to determine whether the combined mandala coloring and music intervention helps reduce cancer fear and anxiety during the cancer screening process.
The findings of this study may provide information about whether a simple, low-cost, and non-drug intervention can be used to support women attending cancer screening and make the screening experience less stressful.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Ağri
-
Ağrı, Ağri, Turquía (Türkiye), 04100
- Ağrı İbrahim Çeçen University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
Being a woman aged 30-65 years.
*Applying for cancer screening for the first time or for routine screening.
- Being able to read and write in Turkish.
- Providing voluntary informed consent to participate in the study.
Exclusion Criteria:
- Having a diagnosed psychiatric disorder.
- Having a hearing impairment severe enough to interfere with the music intervention.
- Having a history of diagnosed cancer.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: 1 mandala
Participants will receive a 20-minute mandala intervention before the screening procedure.
|
Participants will receive a 20-minute mandala coloring intervention before the screening procedure.
|
|
Sin intervención: 3 control
control
|
|
|
Experimental: 2 musıc
Participants will receive a 20-minute music intervention before the screening procedure.
|
**Participants will receive a 20-minute music intervention before the screening procedure.**
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
2. Fear of Cancer Scale (FOCS)
Periodo de tiempo: Baseline (immediately before the intervention) and immediately after the 30-minute intervention
|
The Fear of Cancer Scale (FOCS) was developed by Feng and colleagues and the validity and reliability study of the Turkish version was conducted by Öztürk and Kuday. The scale consists of 17 items and two subscales: Direct Fear (items 1, 2, 4, 8, 9, 10, 12, and 13) and Indirect Fear (items 3, 5, 6, 7, 11, 14, 15, 16, and 17). Each item is rated on a 5-point Likert scale ranging from 0 to 4 (0 = Strongly Disagree, 1 = Disagree, 2 = Neither Agree nor Disagree, 3 = Agree, and 4 = Strongly Agree). The total score ranges from 0 to 68, with higher scores indicating greater fear of cancer. The overall Cronbach's alpha coefficient of the scale was reported as 0.920. The Cronbach's alpha coefficients were 0.870 for the Direct Fear subscale and 0.861 for the Indirect Fear subscale. |
Baseline (immediately before the intervention) and immediately after the 30-minute intervention
|
|
1. Personal Information Form
Periodo de tiempo: Baseline
|
The Personal Information Form was developed by the researchers based on the relevant literature and includes questions assessing the participants' sociodemographic characteristics.
|
Baseline
|
|
3. State Anxiety Inventory (STAI-I)
Periodo de tiempo: Baseline (immediately before the intervention) and immediately after the 30-minute intervention
|
According to Öner and Le Compte, anxiety can be conceptualized as two distinct forms: state anxiety and trait anxiety. This distinction was initially proposed through the factor-analytic studies of Cattell and Scheier and subsequently formed the basis of the two-factor theory of anxiety developed through the work of Spielberger and colleagues The State-Trait Anxiety Inventory is a self-report instrument consisting of brief statements designed to assess anxiety. Although it was originally developed to assess anxiety among psychiatrically healthy adults, subsequent studies have demonstrated its applicability to high school students as well as individuals with psychiatric and physical health conditions. |
Baseline (immediately before the intervention) and immediately after the 30-minute intervention
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Nurten OZCALKAP, asisst. prof, Agri Ibrahim Cecen University
Publicaciones y enlaces útiles
Publicaciones Generales
- Oner N, Le Compte A. Durumluk-Sürekli kaygı envanteri elkitabı, 20. Basım İstanbul: Boğaziçi Üniversitesi Yayınları, 1985. s.3-5.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Desordenes mentales
- Neoplasias
- Desórdenes de ansiedad
- Patofobia
- Terapéutica
- Terapias complementarias
- Atención al paciente
- Psicoterapia
- Disciplinas y actividades de comportamiento
- Rehabilitación
- Cuidado por los convalecientes
- Continuidad de la atención al paciente
- Terapias de arte sensorial
- Musicoterapia
Otros números de identificación del estudio
- AICU-KETEM-157-2026
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .